OncoCyte Corp (OCX)

[DMOST]

From the prospectus...........OCX

DILUTION

If you invest in our common stock in this offering, your interest will be immediately diluted to the extent of the difference between the offering price per share you will pay in this offering and the as adjusted net tangible book value per share of our common stock immediately after this offering.

Our net tangible book value as of September 30, 2018 was approximately $7.5 million, or $0.19 per share. Our net tangible book value is the amount of our total tangible assets less our total liabilities. Net tangible book value per share represents net tangible book value divided by the total number of shares of our common stock outstanding as of September 30, 2018.

After giving effect to the issuance and sale of 9,333,334 shares of common stock in this offering at the public offering price of $3.75 per share, after deducting the underwriting discounts and commissions and estimated offering expenses payable by us, the as adjusted net tangible book value as of September 30, 2018 would have been approximately $39.6 million, or $0.79 per share. This represents an immediate increase in net tangible book value of approximately $0.60 per share to our existing shareholders and an immediate dilution in as-adjusted net tangible book value of approximately $2.96 per share to purchasers of our securities in this offering. We determine dilution per share to investors participating in this offering by subtracting as adjusted net tangible book value per share after this offering from the assumed public offering price per share paid by investors participating in this offering.
https://ih.advfn.com/stock-market/AMEX/oncocyte-corp-OCX/stock-news/79227893/prospectus-filed-pursuant-to-rule-424b5-424b5#FORM424B5_HTM_B_007


Looking for it to drift down to near this $2.96 price or below before the next quarter and "Public Share offering", with some chance of positive news, before the announcement, to bolster the price.

GO OCX

"PEACE"